跳至主要内容
临床试验/CTRI/2022/01/039808
CTRI/2022/01/039808已完成不适用

AN ASSESSMENT OF QUALITY OF LIFE IN UTHIRAVATHA SURONITHAM(RHEUMATOID ARTHRITIS)PATIENTS REPORTING AT AYOTHIDOSS PANDITHAR HOSPITAL NATIONAL INSTITUTE OF SIDDHA A CROSS SECTIONAL STUDY

National Institute of Siddha1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年1月2日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
The outcome of this study will provide validate measure of quality of life and provide a tool for improving the evaluation of siddha medications for Uthiravatha Suronitham

研究概览

简要总结

Rheumatoid arthritis is the most commonpersistent inflammatory arthritis. The symptoms are pain, joint swelling andstiffness affecting the small joints of the hand, feet, and wrists. Large jointinvolvement, systemic symptoms and extra articular features may also occur. OBJECTIVE: To estimate the quality of life (QOL) inUthiravatha suronitham patients reporting at OPD of Ayothidoss Panditharhospital, NIS through Rheumatoid Arthritis Flare Questionnaire (RA-FQ) and toassess the predisposing factors of Uthiravatha suronitham with respect age,gender, chronicity of illness, personal history, occupational history, familyhistory, stress etc. MATERIALS ANDMETHODS: This is a Hospital based crosssectional study, included 100  Uthiravatha suronitham patients reported OPDof ayothidoss pandithar hospital were enrolled  based on inclusion  and exclusion criteria. After obtaininginformed consent form, data were collected by using  Rheumatoid Arthritis Flare Questionnaire(RA-FQ) and Beck’s Depression Inventory form to estimate the quality of life. RESULTS : In 100 Uthiravatha suronithampatients, over all  score is 42.9 in  RA-FQ (Maximum 50) questionnaire. In beck’sdepression Inventory showed that  38%patients had Moderate depression and 33% patients had Severe depression. CONCLUSION: Rheumatoid arthritissignificantly affects the quality of life of patients both physically andmentally.

研究设计

研究类型
Observational

入排标准

年龄范围
30.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Age 30 TO 65 Years Male Female and Transgender K/C/O Uthiravatha suronitham(Rheumatoid Arthritis)patients with sero negative sero positive RA Lab investigations patients who are willing to give informed consent.

排除标准

  • Age below 30 and above 65 years Patients with normal CRP Anti CCP test results Patient who are not willing to give consent form Patients defects (Osteoarthritis Psoriatic arthritis Gout arthritis).

结局指标

主要结局

The outcome of this study will provide validate measure of quality of life and provide a tool for improving the evaluation of siddha medications for Uthiravatha Suronitham

时间窗: 6months

次要结局

未报告次要终点

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验